{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:42:28Z","timestamp":1781710948855,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-04178-y","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T21:14:14Z","timestamp":1743714854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of The efficacy and safety of fractional erbium: YAG laser in combination with Tranexamic acid delivery by different methods versus Tranexamic acid alone: A systematic review and meta-analysis"],"prefix":"10.1007","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0367-4616","authenticated-orcid":false,"given":"Sara Mahfoud Hassan","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7661-2025","authenticated-orcid":false,"given":"Ahmed Mohammed","family":"Baabdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4423-0233","authenticated-orcid":false,"given":"Dareen","family":"Bajamaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5133-5162","authenticated-orcid":false,"given":"Razan","family":"Almleaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6552-8795","authenticated-orcid":false,"given":"Mohammed","family":"Alahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9767-9297","authenticated-orcid":false,"given":"Mashael","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0400-6461","authenticated-orcid":false,"given":"Badr Salem","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2990-5873","authenticated-orcid":false,"given":"Rayan","family":"Alsaqri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-8161","authenticated-orcid":false,"given":"Abdulrahman Ayman","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"4178_CR1","doi-asserted-by":"publisher","unstructured":"Handel AC, Miot LDB, Miot HA (2014) Melasma: a clinical and epidemiological review. Anais Brasileiros De Dermatologia [Internet] 89(5):771\u201382. Available from: https:\/\/doi.org\/10.1590\/abd1806-4841.20143063","DOI":"10.1590\/abd1806-4841.20143063"},{"key":"4178_CR2","doi-asserted-by":"publisher","unstructured":"Freitag F, Cestari T, Leopoldo L, Paludo P, Boza J (2008) Effect of melasma on quality of life in a sample of women living in southern Brazil. Journal of the European Academy of Dermatology and Venereology [Internet] 22(6):655\u201362. Available from: https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02472.x","DOI":"10.1111\/j.1468-3083.2007.02472.x"},{"key":"4178_CR3","doi-asserted-by":"publisher","unstructured":"Ogbechie-Godec OA, Elbuluk N (2017) Melasma: an Up-to-Date Comprehensive Review. Dermatology and Therapy [Internet] 7(3):305\u201318. Available from: https:\/\/doi.org\/10.1007\/s13555-017-0194-1","DOI":"10.1007\/s13555-017-0194-1"},{"key":"4178_CR4","doi-asserted-by":"publisher","unstructured":"Polnikorn N (2010) Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: A prospective study. Journal of Cosmetic and Laser Therapy [Internet] 12(3):126\u201331. Available from: https:\/\/doi.org\/10.3109\/14764172.2010.487910","DOI":"10.3109\/14764172.2010.487910"},{"key":"4178_CR5","doi-asserted-by":"publisher","unstructured":"Rodrigues M, Pandya AG (2015) Melasma: clinical diagnosis and management options. Australasian Journal of Dermatology [Internet] 56(3):151\u201363. Available from: https:\/\/doi.org\/10.1111\/ajd.12290","DOI":"10.1111\/ajd.12290"},{"key":"4178_CR6","doi-asserted-by":"publisher","unstructured":"Neagu N, Conforti C, Agozzino M, Marangi GF, Morariu SH, Pellacani G et al (2021) Melasma treatment: a systematic review. Journal of Dermatological Treatment [Internet] 33(4):1816\u201337. Available from: https:\/\/doi.org\/10.1080\/09546634.2021.1914313","DOI":"10.1080\/09546634.2021.1914313"},{"key":"4178_CR7","doi-asserted-by":"publisher","unstructured":"Cheng L, Pettersen D, Ohlsson B, Schell P, Karle M, Evertsson E et al (2014) Discovery of the fibrinolysis inhibitor AZD6564, acting via interference of a Protein-Protein interaction. ACS Medicinal Chemistry Letters [Internet] 5(5):538\u201343. Available from: https:\/\/doi.org\/10.1021\/ml400526d","DOI":"10.1021\/ml400526d"},{"key":"4178_CR8","doi-asserted-by":"publisher","unstructured":"Botsali A, Esme P, Erbil H, Caliskan E (2022) Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and combined with oral tranexamic acid in melasma. Lasers in Medical Science [Internet] 37(7):2823\u201330. Available from: https:\/\/doi.org\/10.1007\/s10103-022-03547-7","DOI":"10.1007\/s10103-022-03547-7"},{"key":"4178_CR9","doi-asserted-by":"publisher","unstructured":"Qu Y, Wang F, Liu J, Xia X (2021) Clinical observation and dermoscopy evaluation of fractional CO2 laser combined with topical tranexamic acid in melasma treatments. Journal of Cosmetic Dermatology [Internet] 20(4):1110\u20136. Available from: https:\/\/doi.org\/10.1111\/jocd.13992","DOI":"10.1111\/jocd.13992"},{"key":"4178_CR10","doi-asserted-by":"publisher","unstructured":"Kamal SM, Hegab DS, Maghraby GME, Ashmawy AAE (2023) Efficacy and Safety of Topical Tranexamic Acid Alone or in Combination with Either Fractional Carbon Dioxide Laser or Microneedling for the Treatment of Melasma. Dermatology Practical & Conceptual [Internet] e2023195. Available from: https:\/\/doi.org\/10.5826\/dpc.1303a195","DOI":"10.5826\/dpc.1303a195"},{"key":"4178_CR11","doi-asserted-by":"publisher","unstructured":"Atefi N, Yeganeh ZP, Bazargan AS, Yeganeh MSP, Jafarzadeh A, Zare M et al (2025) Evaluation of the efficacy, safety, and satisfaction rate of topical latanoprost in patients with hypopigmented burn scars treated with fractional CO2 laser: a double-blind randomized controlled clinical trial. Lasers Med Sci [Internet] 40(1):14. Available from: https:\/\/doi.org\/10.1007\/s10103-024-04259-w","DOI":"10.1007\/s10103-024-04259-w"},{"key":"4178_CR12","doi-asserted-by":"publisher","unstructured":"Roohaninasab M, Jafarzadeh A, Sadeghzadeh-Bazargan A, Zare S, Nouri M, Nilforoushzadeh MA et al (2024) Evaluation of the efficacy, safety and satisfaction rates of platelet-rich plasma, non-cross-linked hyaluronic acid and the combination of platelet-rich plasma and non-cross-linked hyaluronic acid in patients with burn scars treated with fractional CO2 laser: A randomized controlled clinical trial. Int Wound J [Internet] 21(10):e70065. Available from: https:\/\/doi.org\/10.1111\/iwj.70065","DOI":"10.1111\/iwj.70065"},{"key":"4178_CR13","doi-asserted-by":"publisher","unstructured":"Agamia N, Apalla Z, Salem W, Abdallah W (2020) A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation. Journal of Dermatological Treatment [Internet] 32(7):819\u201326. Available from: https:\/\/doi.org\/10.1080\/09546634.2019.1708847","DOI":"10.1080\/09546634.2019.1708847"},{"key":"4178_CR14","doi-asserted-by":"publisher","unstructured":"Debasmita B, Raj C, Ishan A, Ipsita D (2021) A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma. Journal of Cosmetic Dermatology [Internet] 21(7):2801\u20137. Available from: https:\/\/doi.org\/10.1111\/jocd.14532","DOI":"10.1111\/jocd.14532"},{"key":"4178_CR15","doi-asserted-by":"publisher","unstructured":"Otb S, Shaarawy E, Sadek A, Abdallah N, Agamia N, Soliman M et al (2020) A split-face comparative study between intradermal tranexamic acid and Erbium-YAG laser in the treatment of melasma. Journal of Dermatological Treatment [Internet] 33(1):555\u20139. Available from: https:\/\/doi.org\/10.1080\/09546634.2020.1771259","DOI":"10.1080\/09546634.2020.1771259"},{"key":"4178_CR16","doi-asserted-by":"publisher","unstructured":"Behrangi E, Shemshadi M, Ghassemi M, Goodarzi A, Dilmaghani S (2021) Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064\u2010nm Nd:YAG laser: A blinded RCT and follow\u2010up. Journal of Cosmetic Dermatology [Internet] 21(1):279\u201389. Available from: https:\/\/doi.org\/10.1111\/jocd.14496","DOI":"10.1111\/jocd.14496"},{"key":"4178_CR17","doi-asserted-by":"publisher","unstructured":"Elkamshoushi AM, Romisy D, Omar SS (2021) Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q\u2010switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation. Journal of Cosmetic Dermatology [Internet] 21(2):657\u201368. Available from: https:\/\/doi.org\/10.1111\/jocd.14140","DOI":"10.1111\/jocd.14140"},{"key":"4178_CR18","doi-asserted-by":"publisher","unstructured":"Cho HH, Choi M, Cho S, Lee JH (2011) Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser. Journal of Dermatological Treatment [Internet] 24(4):292\u20136. Available from: https:\/\/doi.org\/10.3109\/09546634.2011.643220","DOI":"10.3109\/09546634.2011.643220"},{"key":"4178_CR19","doi-asserted-by":"publisher","unstructured":"Hawwam SA, Ismail M, El-Attar YA (2022) Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation. Lasers in Medical Science [Internet] 37(4):2193\u2013201. Available from: https:\/\/doi.org\/10.1007\/s10103-021-03483-y","DOI":"10.1007\/s10103-021-03483-y"},{"key":"4178_CR20","doi-asserted-by":"publisher","unstructured":"Beyzaee AM, Patil A, Goldust M, Moslemi M, Kazeminejad A, Rokni GR (2021) Comparative Efficacy of Fractional CO2 Laser and Q-Switched Nd:YAG Laser in Combination Therapy with Tranexamic Acid in Refractory Melasma: Results of a Prospective Clinical Trial. Cosmetics [Internet] 8(2):37. Available from: https:\/\/doi.org\/10.3390\/cosmetics8020037","DOI":"10.3390\/cosmetics8020037"},{"key":"4178_CR21","doi-asserted-by":"publisher","unstructured":"Zappia E, Piccolo D, Del Re C, Bonan P, Guarino L, Ribero S et al (2024) Combined Efficacy of Q-Switched 785 nm Laser and Tranexamic Acid Cream in the Treatment of Melasma: A Prospective Clinical Study. Photonics [Internet] 11(10):938. Available from: https:\/\/doi.org\/10.3390\/photonics11100938","DOI":"10.3390\/photonics11100938"},{"key":"4178_CR22","doi-asserted-by":"publisher","unstructured":"Park SJ, Park JW, Seo SJ, Park KY (2021) Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single-center, prospective, split\u2010face trial. Dermatologic Therapy [Internet] 35(3). Available from: https:\/\/doi.org\/10.1111\/dth.15287","DOI":"10.1111\/dth.15287"},{"key":"4178_CR23","doi-asserted-by":"publisher","unstructured":"Laothaworn V, Juntongjin P (2018) Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma. Journal of Cosmetic and Laser Therapy [Internet] 20(6):320\u20135. Available from: https:\/\/doi.org\/10.1080\/14764172.2018.1427869","DOI":"10.1080\/14764172.2018.1427869"},{"key":"4178_CR24","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1111\/jocd.16464","volume":"23","author":"SB Aghdam","year":"2024","unstructured":"Aghdam SB, Mohammad AP, Hosseini-Baharanchi FS, Atefi N, Roohaninasab M, Kahjoogh HA et al (2024) Efficacy, safety, tolerability and treatment durability of microneedling plus topical Tranexamic acid in combination with topical modified Kligman lightening formula for melasma: A four-arm assessor and analyst blinded randomized controlled clinical trial. J Cosmet Dermatol 23:3585\u20133597. https:\/\/doi.org\/10.1111\/jocd.16464","journal-title":"J Cosmet Dermatol"},{"key":"4178_CR25","unstructured":"Chen X, Wu J, Cai M, Shi F, Wu L (2019) The efficacy of 1064-nm Q-switched Nd: YAG laser combined with tranexamic acid, glutathione, and vitamin C in the treatment of chloasma [Internet] Available from: https:\/\/www.semanticscholar.org\/paper\/The-efficacy-of-1064-nm-Q-switched-Nd%3A-YAG-laser-C-Chen-Wu\/0f0eea70b9bf0692353c5bff6797e9f82a873294"},{"key":"4178_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/14764172.2016.1262960","volume":"19","author":"B Tian","year":"2017","unstructured":"Tian B (2017) Laser toning for melasma: A single-center experience with 38 970 cases. J Cosmet Laser Ther 19:140\u2013142. https:\/\/doi.org\/10.1080\/14764172.2016.1262960","journal-title":"J Cosmet Laser Ther"},{"key":"4178_CR27","first-page":"63","volume":"16","author":"J Kaikati","year":"2023","unstructured":"Kaikati J, El Bcherawi N, Khater JA, Dib SM, Kechichian E, Helou J (2023) Combination topical Tranexamic acid and vitamin C for the treatment of refractory melasma. J Clin Aesthet Dermatol 16:63\u201365","journal-title":"J Clin Aesthet Dermatol"},{"key":"4178_CR28","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/medicina58070936","volume":"58","author":"YS Lee","year":"2022","unstructured":"Lee YS, Lee YJ, Lee JM, Han TY, Lee JH, Choi JE (2022) The low-fluence Q-switched Nd:YAG laser treatment for melasma: A systematic review. Med (Kaunas) 58:936. https:\/\/doi.org\/10.3390\/medicina58070936","journal-title":"Med (Kaunas)"},{"key":"4178_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.36849\/JDD.7104","volume":"22","author":"S Desai","year":"2023","unstructured":"Desai S, Chan L, Handog E, Djojoseputro L, Lim J, Ling R et al (2023) Optimizing melasma management with topical Tranexamic acid: an expert consensus. J Drugs Dermatol 22:386\u2013392. https:\/\/doi.org\/10.36849\/JDD.7104","journal-title":"J Drugs Dermatol"},{"key":"4178_CR30","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3390\/jcm13051468","volume":"13","author":"B Jiryis","year":"2024","unstructured":"Jiryis B, Toledano O, Avitan-Hersh E, Khamaysi Z (2024) Management of melasma: laser and other therapies-review study. J Clin Med 13:1468. https:\/\/doi.org\/10.3390\/jcm13051468","journal-title":"J Clin Med"},{"key":"4178_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/14764172.2014.957217","volume":"17","author":"CP Choi","year":"2015","unstructured":"Choi CP, Yim SM, Seo SH, Ahn HH, Kye YC, Choi JE (2015) Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy. J Cosmet Laser Ther 17:2\u20138. https:\/\/doi.org\/10.3109\/14764172.2014.957217","journal-title":"J Cosmet Laser Ther"},{"key":"4178_CR32","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s10103-022-03514-2","volume":"37","author":"D Lai","year":"2022","unstructured":"Lai D, Zhou S, Cheng S, Liu H, Cui Y (2022) Laser therapy in the treatment of melasma: a systematic review and meta-analysis. Lasers Med Sci 37:2099\u20132110. https:\/\/doi.org\/10.1007\/s10103-022-03514-2","journal-title":"Lasers Med Sci"},{"key":"4178_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/ijdvl.IJDVL_1086_16","volume":"85","author":"SJ Aurangabadkar","year":"2019","unstructured":"Aurangabadkar SJ (2019) Optimizing Q-switched lasers for melasma and acquired dermal melanoses. Indian J Dermatol Venereol Leprol 85:10\u201317. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_1086_16","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4178_CR34","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1111\/jocd.16006","volume":"22","author":"W Ma","year":"2023","unstructured":"Ma W, Gao Q, Liu J, Zhong X, Xu T, Wu Q et al (2023) Efficacy and safety of laser-related therapy for melasma: A systematic review and network meta-analysis. J Cosmet Dermatol 22:2910\u20132924. https:\/\/doi.org\/10.1111\/jocd.16006","journal-title":"J Cosmet Dermatol"},{"key":"4178_CR35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/DSS.0000000000001518","volume":"44","author":"HR Bala","year":"2018","unstructured":"Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M (2018) Oral Tranexamic acid for the treatment of melasma: A review. Dermatol Surg 44:814\u2013825. https:\/\/doi.org\/10.1097\/DSS.0000000000001518","journal-title":"Dermatol Surg"},{"key":"4178_CR36","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/jocd.15589","volume":"22","author":"H Konisky","year":"2023","unstructured":"Konisky H, Balazic E, Jaller JA, Khanna U, Kobets K (2023) Tranexamic acid in melasma: A focused review on drug administration routes. J Cosmet Dermatol 22:1197\u20131206. https:\/\/doi.org\/10.1111\/jocd.15589","journal-title":"J Cosmet Dermatol"},{"key":"4178_CR37","doi-asserted-by":"publisher","unstructured":"Lee DJ, Lee J, Ha J, Park K-C, Ortonne J-P, Kang HY (2012) Defective barrier function in melasma skin: Defective barrier function in melasma skin. J Eur Acad Dermatol Venereol [Internet] 26(12):1533\u20137. Available from: https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04337.x","DOI":"10.1111\/j.1468-3083.2011.04337.x"},{"key":"4178_CR38","doi-asserted-by":"publisher","unstructured":"Jo JY, Chae SJ, Ryu HJ (2024) Update on Melasma treatments. Ann Dermatol [Internet] 36(3):125\u201334. Available from: https:\/\/doi.org\/10.5021\/ad.23.133","DOI":"10.5021\/ad.23.133"},{"key":"4178_CR39","doi-asserted-by":"publisher","unstructured":"Sarkar R, Arora P, Garg VK, Sonthalia S, Gokhale N (2014) Melasma update. Indian Dermatol Online J [Internet] 5(4):426\u201335. Available from: https:\/\/doi.org\/10.4103\/2229-5178.142484","DOI":"10.4103\/2229-5178.142484"},{"key":"4178_CR40","doi-asserted-by":"publisher","unstructured":"Pekmezci E (2019) A novel triple combination in treatment of melasma: Significant outcome with far less actives. J Cosmet Dermatol [Internet] 18(6):1700\u20134. Available from: https:\/\/doi.org\/10.1111\/jocd.12904","DOI":"10.1111\/jocd.12904"},{"key":"4178_CR41","doi-asserted-by":"publisher","first-page":"776","DOI":"10.2340\/00015555-2668","volume":"97","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS (2017) Efficacy and safety of Tranexamic acid in melasma: A meta-analysis and systematic review. Acta Derm Venereol 97:776\u2013781. https:\/\/doi.org\/10.2340\/00015555-2668","journal-title":"Acta Derm Venereol"},{"key":"4178_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40257-019-00488-w","volume":"21","author":"J McKesey","year":"2020","unstructured":"McKesey J, Tovar-Garza A, Pandya AG (2020) Melasma treatment: an evidence-based review. Am J Clin Dermatol 21:173\u2013225. https:\/\/doi.org\/10.1007\/s40257-019-00488-w","journal-title":"Am J Clin Dermatol"},{"key":"4178_CR43","doi-asserted-by":"publisher","unstructured":"Jafari MA, Bazgir G, Hosseini-Baharanchi FS, Jafarzadeh A, Goodarzi A (2024) Efficacy and safety of laser therapy and phototherapy in cicatricial and NonCicatricial alopecia: A systematic review study. Health Sci Rep [Internet] 7(11):e70180. Available from: https:\/\/doi.org\/10.1002\/hsr2.70180","DOI":"10.1002\/hsr2.70180"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-04178-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-04178-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:42:45Z","timestamp":1743741765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-04178-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4178"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-04178-y","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"655"}}